The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Chagas' Heart Disease
Open accessAbstract
Chagas' disease is caused by a protozoan parasite, Trypanosoma cruzi, that is transmitted to humans through the feces of infected bloodsucking insects in endemic areas of Latin America, or occasionally by nonvectorial mechanisms, such as blood transfusion. Cardiac involvement, which typically appears decades after the initial infection, may result in cardiac arrhythmias, ventricular aneurysm, congestive heart failure, thromboembolism, and sudden cardiac death. Between 16 and 18 million persons are infected in Latin America. The migration of infected Latin Americans to the United States or other countries where the disease is uncommon poses two problems: the misdiagnosis or undiagnosis of Chagas' heart disease in these immigrants and the possibility of transmission of Chagas' disease through blood transfusions. Diagnosis is based on positive serologic tests and the clinical features. The antiparasitic drug, benznidazole, is effective when given for the initial infection and may also be beneficial for the chronic phase. The use of amiodarone, angiotensin‐converting enzyme inhibitors, and pacemaker implantation may contribute to a better survival in selected patients with cardiac involvement of chronic Chagas' disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Chagas, C. (1909) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02761909000200008 · Cited by 2,173
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Konstantinou, D. M., Karvounis, H., & Giannakoulas, G. (2016) · Cardiology · doi:10.1159/000444078 · Cited by 870
Partial Left Ventriculectomy to Treat End-Stage Heart Disease
Batista, R. J. V., Verde, J., Nery, P., Bocchino, L., Takeshita, N., Bhayana, J. N., Bergsland, J., Graham, S., Houck, J. P., & Salerno, T. A. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00779-0 · Cited by 377
Cited by
Rassi, A., Rassi, A., & Marin-Neto, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60061-x · Cited by 2,119
Self-citationZipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
Pérez-Molina, J. A., & Molina, I. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31612-4 · Cited by 1,284
Clinical and epidemiological aspects of Chagas disease
Prata, A. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00065-2 · Cited by 923
Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review
Bern, C., Montgomery, S. P., Herwaldt, B. L., Rassi, A., Marin-Neto, J. A., Dantas, R. O., Maguire, J. H., Acquatella, H., Morillo, C., Kirchhoff, L. V., et al. (2007) · JAMA · doi:10.1001/jama.298.18.2171 · Cited by 775
Self-citationWriting Committee Members, Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., et al. (2006) · Europace · doi:10.1093/europace/eul108 · Cited by 738
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Barrett, M. P., Burchmore, R. J., Stich, A., Lazzari, J. O., Frasch, A. C., Cazzulo, J. J., & Krishna, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14694-6 · Cited by 656
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
AMERICAN TRYPANOSOMIASIS (CHAGAS' DISEASE): FIRST INDIGENOUS CASE IN THE UNITED STATES
Woody, N. C. (1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960240042010a · Cited by 533
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl199 · Cited by 523
American Trypanosomiasis (Chagas Disease)
Rassi, A., Rassi, A., & Marcondes de Rezende, J. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.03.002 · Cited by 508
Self-citationSpecific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Urbina, J. A. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.10.023 · Cited by 473
Neglected Infections of Poverty in the United States of America
Hotez, P. J. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000256 · Cited by 365
Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Viotti, R., Vigliano, C., Lococo, B., Alvarez, M. G., Petti, M., Bertocchi, G., & Armenti, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.7.2.157 · Cited by 327
Chagas Disease in the United States: a Public Health Approach
Bern, C., Messenger, L. A., Whitman, J. D., & Maguire, J. H. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-19 · Cited by 282
Waghabi, M. C., de Souza, E. M., de Oliveira, G. M., Keramidas, M., Feige, J.-J., Araújo-Jorge, T. C., & Bailly, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-09 · Cited by 66
Metadata
- Authors
- Jr, A. R., Rassi, A., & Little, W. C.
- Venue
- Clinical Cardiology
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 23
- Issue
- 12
- Pages
- 883-889
- ISSN
- 0160-9289 (ISSN-L)
- 1932-8737
- OpenAlex
- W1979885599
- Cited by
- 317
- References
- 23
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.